On Wednesday shares of Ultrapetrol (Bahamas) Limited (NASDAQ:ULTR) closed at $1.41. Company’s sales growth for last 5 years was 6.30% and EPS growth for next 5 years is recorded as 4.00%. Ultrapetrol (Bahamas) Limited (NASDAQ:ULTR) announced on 29 March 2015, that it had renewed a contract with Petrobras, which expired in March 2015, to employ the UP Turquoise for an additional four years at $30,050 per day, consistent with its previous contract.
On last trading day Pandora Media Inc (NYSE:P) decreased -1.54% to close at $15.96. Its volatility for the week is 3.57% while volatility for the month is 4.15%. P’s sales growth for past 5 years was 75.60%. Pandora Media Inc (NYSE:P) monthly performance is 3.43%. Canaccord Genuity restated their in-line rating on shares of Pandora Media (NYSE:P) in a research note issued to investors on Monday.
On last trading day Oneida Financial Corp. (NASDAQ:ONFC) remains unchanged to close at $19.67. Its volatility for the week is 1.19% while volatility for the month is 1.43%. ONFC’s sales growth for past 5 years was -2.00% and its EPS growth for past 5 years was 4.70%. Oneida Financial Corp. (NASDAQ:ONFC) monthly performance is -0.15%. Top executives at Oneida Financial Corp. (NASDAQ:ONFC) will be in line for big paydays after the bank is acquired by DeWitt-based Community Bank. The $142 million deal is expected to close in July. Oneida Financial is the parent company of Oneida Savings Bank.
Boston Properties Inc. (NYSE:BXP) has 0.70% insider ownership while its institutional ownership stands at 97.80%. In last trading activity company’s stock closed at $139.71. Boston Properties, Inc. (NYSE: BXP) announced that it will release financial results for the First Quarter on Monday, April 27, 2015 after the close of trading on the New York Stock Exchange. The Company will host a conference call and audio web cast, both open to the general public, at 10:00 A.M. Eastern Time on Tuesday, April 28, 2015 to discuss the financial results of the First Quarter and provide a Company update.
Merck & Co. Inc. (NYSE:MRK) has 0.04% insider ownership while its institutional ownership stands at 75.50%. In last trading activity company’s stock closed at $56.86. Merck & Co. Inc. (NYSE:MRK) and Syndax Pharmaceuticals announced that that they have entered into a collaboration under which they will evaluate the safety and efficacy of a combination of Syndax’s epigenetic therapy candidate, entinostat, and Merck’s anti-PD-1 therapy, Keytruda.